These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15498191)
21. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma]. Shi HR; Song WJ; Chen ZM; Wu QH Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439 [TBL] [Abstract][Full Text] [Related]
22. [Expression of DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovarian carcinoma]. Chen CL; Yan X; Gao YN; Liao QP Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):770-4. PubMed ID: 16324253 [TBL] [Abstract][Full Text] [Related]
23. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue]. Tang L; Wang M; Ma J Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927 [TBL] [Abstract][Full Text] [Related]
24. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors. Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754 [TBL] [Abstract][Full Text] [Related]
25. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray]. Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091 [TBL] [Abstract][Full Text] [Related]
26. [Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors]. Fracchioli S; Katsaros D; Maggiora P; Di Renzo MF; Massobrio M Minerva Ginecol; 1999 Oct; 51(10):359-64. PubMed ID: 10638160 [TBL] [Abstract][Full Text] [Related]
27. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related]
28. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279 [TBL] [Abstract][Full Text] [Related]
29. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer]. Qiao YH; Cheng J; Guo RX Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045 [TBL] [Abstract][Full Text] [Related]
30. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors. Li M; Qi SY; Wang Y; Feng SX; Zhang BZ; Wang R Arch Gynecol Obstet; 2005 Jun; 272(1):48-52. PubMed ID: 15682318 [TBL] [Abstract][Full Text] [Related]
31. [Expression of ZNF217 in human ovarian cystadenocarcinoma and its clinical significance]. Sun GQ; Zhong M; Ding YQ; Su GD; Song TR; Yin AL Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):685-8. PubMed ID: 19403395 [TBL] [Abstract][Full Text] [Related]
32. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629 [TBL] [Abstract][Full Text] [Related]
33. [Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients]. Li HX; Zhong S; Li CH Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):290-3. PubMed ID: 12895314 [TBL] [Abstract][Full Text] [Related]
34. Reduction of BRCA1 expression in sporadic ovarian cancer. Zheng W; Luo F; Lu JJ; Baltayan A; Press MF; Zhang ZF; Pike MC Gynecol Oncol; 2000 Mar; 76(3):294-300. PubMed ID: 10684699 [TBL] [Abstract][Full Text] [Related]
35. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Kim CH; Kim J; Kahng H; Choi EC Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients. Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446 [TBL] [Abstract][Full Text] [Related]
38. [Expression of aFGF and bFGF in ovarian cancer and their effect on ovarian cancer cell proliferation]. Zhang Y; Shang H; Sun LG; Liu N; Yu HY Ai Zheng; 2003 Nov; 22(11):1162-5. PubMed ID: 14613644 [TBL] [Abstract][Full Text] [Related]
39. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma]. Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898 [TBL] [Abstract][Full Text] [Related]
40. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]. Gao GL; Liu LD; Zou XS; Chen WX Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]